
Recent data show that drug overdose deaths in the U.S. were 10 percent higher in 2017 than 2016, with an almost 50 percent increase in those related to synthetic opioids. A new research paper points to a glimmer of hope in this otherwise bleak story: Medicare Advantage insurance companies seem to be doing a surprisingly good job at mitigating opioid abuse.
Medicare plays a larger role in the epidemic than many people may appreciate. The program is the largest single purchaser of opioids; it accounts for more than a fifth of prescription opioid spending and in 2017 alone spent more than $3 billion on these drugs. And use is relatively widespread: Almost a third of people receiving drug coverage through Medicare obtained an opioid prescription last year. Some research even suggests the expansion of drug coverage under Medicare's Part D is partially responsible for the problem, by reducing the cost of prescribed drugs to consumers (even if the people receiving the lower-cost prescriptions diverted the drugs to others).
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to asset-and-logo-licensing@alm.com. For more information visit Asset & Logo Licensing.